Brain IL-6 and autism

Neuroscience

Volumn 252, Issue , 2013, Pages 320-325

  Wei, H ^a   Alberts, I ^b   Li, X ^c  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Autism; Behavior; Brain; Interleukin 6; Neuroimmune response

Indexed keywords

INTERLEUKIN 6;

AUTISM; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; DRUG MECHANISM; ENVIRONMENTAL FACTOR; GENETIC DISORDER; HEREDITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROANATOMY; NEUROIMMUNOLOGY; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SOCIAL BEHAVIOR; SOCIAL INTERACTION;

AUTISM; BEHAVIOR; BRAIN; CEREBROSPINAL FLUID; CSF; GM-CSF; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IFN-Γ; IL; INTERFERON-Γ; INTERLEUKIN; INTERLEUKIN-6; MACROPHAGE CHEMOATTRACTANT PROTEIN; MAGNETIC RESONANCE IMAGING; MATERNAL IMMUNE ACTIVATION; MCP; MIA; MRI; NEUROIMMUNE RESPONSE; TNF-Α; TUMOR NECROSIS FACTOR ALPHA;

ANIMALS; AUTISTIC DISORDER; BRAIN; HUMANS; INTERLEUKIN-6; NEUROIMMUNOMODULATION;

EID: 84884369430     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.08.025     Document Type: Review

References (81)

1. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008, 9:341-355.
2. Alarcon M., Abrahams B.S., Stone J.L., Duvall J.A., Perederiy J.V., Bomar J.M., Sebat J., Wigler M., Martin C.L., Ledbetter D.H., Nelson S.F., Cantor R.M., Geschwind D.H. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008, 82:150-159.
3. Arking D.E., Cutler D.J., Brune C.W., Teslovich T.M., West K., Ikeda M., Rea A., Guy M., Lin S., Cook E.H., Chakravarti A. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008, 82:160-164.
4. Ashwood P., Anthony A., Torrente F., Wakefield A.J. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 2004, 24:664-673.
5. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011, 25:40-45.
6. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I.N., Van de Water J. Altered T cell responses in children with autism. Brain Behav Immun 2011, 25:840-849.
7. Bakkaloglu B., O'Roak B.J., Louvi A., Gupta A.R., Abelson J.F., Morgan T.M., Chawarska K., Klin A., Ercan-Sencicek A.G., Stillman A.A., Tanriover G., Abrahams B.S., Duvall J.A., Robbins E.M., Geschwind D.H., Biederer T., Gunel M., Lifton R.P., State M.W. Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 2008, 82:165-173.
8. Bauman M., Kemper T.L. Histoanatomic observations of the brain in early infantile autism. Neurology 1985, 35:866-874.
9. Benveniste E.N. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 1998, 9:259-275.
10. Bittner T., Fuhrmann M., Burgold S., Ochs S.M., Hoffmann N., Mitteregger G., Kretzschmar H., LaFerla F.M., Herms J. Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS One 2010, 5:e15477.
11. Boulanger L.M. Immune proteins in brain development and synaptic plasticity. Neuron 2009, 64:93-109.
12. Buehler M.R. A proposed mechanism for autism: an aberrant neuroimmune response manifested as a psychiatric disorder. Med Hypotheses 2011, 76:863-870.
13. Buxbaum J.D., Baron-Cohen S., Devlin B. Genetics in psychiatry: common variant association studies. Mol Autism 2010, 1:6.
14. Canitano R. Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry 2007, 16:61-66.
15. Chez M.G., Dowling T., Patel P.B., Khanna P., Kominsky M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 2007, 36:361-365.
16. Chez M.G., Guido-Estrada N. Immune therapy in autism: historical experience and future directions with immunomodulatory therapy. Neurotherapeutics 2010, 7:293-301.
17. Conroy S.M., Nguyen V., Quina L.A., Blakely-Gonzales P., Ur C., Netzeband J.G., Prieto A.L., Gruol D.L. Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures. J Neuroimmunol 2004, 155:43-54.
18. Courchesne E., Campbell K., Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 2011, 1380:138-145.
19. Courchesne E., Carper R., Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003, 290:337-344.
20. DeFelice M.L., Ruchelli E.D., Markowitz J.E., Strogatz M., Reddy K.P., Kadivar K., Mulberg A.E., Brown K.A. Intestinal cytokines in children with pervasive developmental disorders. Am J Gastroenterol 2003, 98:1777-1782.
21. Devlin B., Melhem N., Roeder K. Do common variants play a role in risk for autism? Evidence and theoretical musings. Brain Res 2011, 1380:78-84.
22. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsater H., Sponheim E., Goubran-Botros H., Delorme R., Chabane N., Mouren-Simeoni M.C., de Mas P., Bieth E., Roge B., Heron D., Burglen L., Gillberg C., Leboyer M., Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007, 39:25-27.
23. Emanuele E., Orsi P., Boso M., Broglia D., Brondino N., Barale F., di Nemi S.U., Politi P. Low-grade endotoxemia in patients with severe autism. Neurosci Lett 2010, 471:162-165.
24. Enstrom A.M., Onore C.E., Van de Water J.A., Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 2010, 24:64-71.
25. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., Shi L., Sidwell R. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002, 22:25-33.
26. Gadient R.A., Otten U.H. Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997, 52:379-390.
27. Ganguli R., Yang Z., Shurin G., Chengappa K.N., Brar J.S., Gubbi A.V., Rabin B.S. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 1994, 51:1-10.
28. Garay P.A., McAllister A.K. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front Synaptic Neurosci 2010, 2:136.
29. Garbett K., Ebert P.J., Mitchell A., Lintas C., Manzi B., Mirnics K., Persico A.M. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 2008, 30:303-311.
30. Gilmore J.H., Fredrik Jarskog L., Vadlamudi S., Lauder J.M. Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology 2004, 29:1221-1229.
31. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000, 57:65-73.
32. Goines P.E., Croen L.A., Braunschweig D., Yoshida C.K., Grether J., Hansen R., Kharrazi M., Ashwood P., Van de Water J. Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Mol Autism 2011, 2:13.
33. Hagberg H., Gressens P., Mallard C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol 2012, 71:444-457.
34. Hallmayer J., Cleveland S., Torres A., Phillips J., Cohen B., Torigoe T., Miller J., Fedele A., Collins J., Smith K., Lotspeich L., Croen L.A., Ozonoff S., Lajonchere C., Grether J.K., Risch N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 2011, 68:1095-1102.
35. Heo Y., Zhang Y., Gao D., Miller V.M., Lawrence D.A. Aberrant immune responses in a mouse with behavioral disorders. PLoS One 2011, 6:e20912.
36. Hutsler J.J., Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res 2010, 1309:83-94.
37. Irwin S.A., Patel B., Idupulapati M., Harris J.B., Crisostomo R.A., Larsen B.P., Kooy F., Willems P.J., Cras P., Kozlowski P.B., Swain R.A., Weiler I.J., Greenough W.T. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet 2001, 98:161-167.
38. Juillerat-Jeanneret L., Fioroni P., Leuenberger P. Modulation of secretion of interleukin-6 in brain-derived microvascular endothelial cells. Endothelium 1995, 3:31-37.
39. Juttler E., Tarabin V., Schwaninger M. Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity. Neuroscientist 2002, 8:268-275.
40. Jyonouchi H., Sun S., Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001, 120:170-179.
41. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., Lally E., Weiss L.A., Najm J., Kutsche K., Descartes M., Holt L., Braddock S., Troxell R., Kaplan L., Volkmar F., Klin A., Tsatsanis K., Harris D.J., Noens I., Pauls D.L., Daly M.J., MacDonald M.E., Morton C.C., Quade B.J., Gusella J.F. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008, 82:199-207.
42. Knobloch M., Mansuy I.M. Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol 2008, 37:73-82.
43. Li X., Chauhan A., Sheikh A.M., Patil S., Chauhan V., Li X.M., Ji L., Brown T., Malik M. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009, 207:111-116.
44. Malik M., Sheikh A.M., Wen G., Spivack W., Brown W.T., Li X. Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 2011, 216:80-85.
45. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., Thiruvahindrapduram B., Fiebig A., Schreiber S., Friedman J., Ketelaars C.E., Vos Y.J., Ficicioglu C., Kirkpatrick S., Nicolson R., Sloman L., Summers A., Gibbons C.A., Teebi A., Chitayat D., Weksberg R., Thompson A., Vardy C., Crosbie V., Luscombe S., Baatjes R., Zwaigenbaum L., Roberts W., Fernandez B., Szatmari P., Scherer S.W. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008, 82:477-488.
46. McAllister A.K., Patterson P.H. Introduction to special issue on neuroimmunology in brain development and disease. Dev Neurobiol 2012, 72:1269-1271.
47. Meyer U., Feldon J., Dammann O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?. Pediatr Res 2011, 69:26R-33R.
48. Molloy C.A., Morrow A.L., Meinzen-Derr J., Schleifer K., Dienger K., Manning-Courtney P., Altaye M., Wills-Karp M. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006, 172:198-205.
49. Morgan J.T., Chana G., Pardo C.A., Achim C., Semendeferi K., Buckwalter J., Courchesne E., Everall I.P. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol Psychiatry 2010, 68:368-376.
50. Morrow E.M., Yoo S.Y., Flavell S.W., Kim T.K., Lin Y., Hill R.S., Mukaddes N.M., Balkhy S., Gascon G., Hashmi A., Al-Saad S., Ware J., Joseph R.M., Greenblatt R., Gleason D., Ertelt J.A., Apse K.A., Bodell A., Partlow J.N., Barry B., Yao H., Markianos K., Ferland R.J., Greenberg M.E., Walsh C.A. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223.
51. Nakanishi M., Niidome T., Matsuda S., Akaike A., Kihara T., Sugimoto H. Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur J Neurosci 2007, 25:649-658.
52. Nimchinsky E.A., Sabatini B.L., Svoboda K. Structure and function of dendritic spines. Annu Rev Physiol 2002, 64:313-353.
53. Oh J., McCloskey M.A., Blong C.C., Bendickson L., Nilsen-Hamilton M., Sakaguchi D.S. Astrocyte-derived interleukin-6 promotes specific neuronal differentiation of neural progenitor cells from adult hippocampus. J Neurosci Res 2010, 88:2798-2809.
54. Onore C., Careaga M., Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 2012, 26:383-392.
55. Pardo-Villamizar C.A., Zimmerman A.W. Inflammation and neuroimmunity in the pathogenesis of autism: neural and immune network interactions. Autism: oxidative stress, inflammation, and immune abnormalities 2009, 225-244. CRC Press.
56. Parker-Athill E., Luo D., Bailey A., Giunta B., Tian J., Shytle R.D., Murphy T., Legradi G., Tan J. Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism. J Neuroimmunol 2009, 217:20-27.
57. Parker-Athill E.C., Tan J. Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway. Neurosignals 2010, 18:113-128.
58. Patterson P.H. Maternal infection and immune involvement in autism. Trends Mol Med 2011, 17:389-394.
59. Peca J., Feliciano C., Ting J.T., Wang W., Wells M.F., Venkatraman T.N., Lascola C.D., Fu Z., Feng G. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
60. Peng Y.P., Qiu Y.H., Lu J.H., Wang J.J. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci Lett 2005, 374:192-196.
61. Ritvo E.R., Freeman B.J., Scheibel A.B., Duong T., Robinson H., Guthrie D., Ritvo A. Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 1986, 143:862-866.
62. Samuelsson A.M., Jennische E., Hansson H.A., Holmang A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1345-R1356.
63. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007, 27:10695-10702.
64. Spooren A., Kolmus K., Laureys G., Clinckers R., De Keyser J., Haegeman G., Gerlo S. Interleukin-6, a mental cytokine. Brain Res Rev 2011, 67:157-183.
65. Suzuki K., Matsuzaki H., Iwata K., Kameno Y., Shimmura C., Kawai S., Yoshihara Y., Wakuda T., Takebayashi K., Takagai S., Matsumoto K., Tsuchiya K.J., Iwata Y., Nakamura K., Tsujii M., Sugiyama T., Mori N. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS One 2011, 6:e20470.
66. Sweet R.A., Henteleff R.A., Zhang W., Sampson A.R., Lewis D.A. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 2009, 34:374-389.
67. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Sudhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
68. Theoharides T.C., Kempuraj D., Redwood L. Autism: an emerging 'neuroimmune disorder' in search of therapy. Expert Opin Pharmacother 2009, 10:2127-2143.
69. van Kammen D.P., McAllister-Sistilli C.G., Kelley M.E., Gurklis J.A., Yao J.K. Elevated interleukin-6 in schizophrenia. Psychiatry Res 1999, 87:129-136.
70. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:67-81.
71. Vereyken E.J., Bajova H., Chow S., de Graan P.N., Gruol D.L. Chronic interleukin-6 alters the level of synaptic proteins in hippocampus in culture and in vivo. Eur J Neurosci 2007, 25:3605-3616.
72. Wang X.C., Qiu Y.H., Peng Y.P. Interleukin-6 protects cerebellar granule neurons from NMDA-induced neurotoxicity. Sheng Li Xue Bao 2007, 59:150-156.
73. Wang X.Q., Peng Y.P., Lu J.H., Cao B.B., Qiu Y.H. Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci Lett 2009, 450:122-126.
74. Wei H., Chadman K.K., McCloskey D.P., Sheikh A.M., Malik M., Brown W.T., Li X. Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors. Biochim Biophys Acta 2012, 1822:831-842.
75. Wei H., Mori S., Hua K., Li X. Alteration of brain volume in IL-6 overexpressing mice related to autism. Int J Dev Neurosci 2012, 30:554-559.
76. Wei H., Zou H., Sheikh A.M., Malik M., Dobkin C., Brown W.T., Li X. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflamm 2011, 8:52.
77. Weiss L.A. Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans. Expert Rev Mol Diagn 2009, 9:795-803.
78. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011, 25:181-213.
79. Yuste R., Bonhoeffer T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 2001, 24:1071-1089.
80. Zhang P., Chebath J., Lonai P., Revel M. Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling. Stem Cells 2004, 22:344-354.
81. Zhang P.L., Levy A.M., Ben-Simchon L., Haggiag S., Chebath J., Revel M. Induction of neuronal and myelin-related gene expression by IL-6-receptor/IL-6: a study on embryonic dorsal root ganglia cells and isolated Schwann cells. Exp Neurol 2007, 208:285-296.